SERPENTI, FABIO
SERPENTI, FABIO
Universita' degli Studi di MILANO
Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience
2023 G. Cassanello, F. Serpenti, F. Bagnoli, G. Saporiti, M. Goldaniga, F. Cavallaro, K. Barbullushi, V. Bellani, G. Galassi, F. Onida
Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features
2023 B. Fattizzo, F. Serpenti, F. Versino, G. Cassanello, L.M. Cro, M. Barbieri, G.A. Croci, N. Revelli, M.G. Della Porta, W. Barcellini
Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse
2022 F. Serpenti, M. Sciumè, G. Galassi, G. Saporiti, F. Grifoni, N. Rampi, F. Cavallaro, K. Barbullushi, E. Tagliaferri, M. Goldaniga, L. Baldini, N.S. Fracchiolla, F. Onida
Hypoplastic myelodysplastic syndromes: Just an overlap syndrome?
2021 B. Fattizzo, F. Serpenti, W. Barcellini, C. Caprioli
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin
2021 M. Sciume, F. Serpenti, S. Muratori, V. Pravettoni, F.M. Ulivieri, G.A. Croci, A.C. Migliorini, A. Esposito, M.C. Goldaniga, G.N. Saporiti, G. Galassi, L. Baldini, F. Onida, F.I. Grifoni
Difficult cases of paroxysmal nocturnal hemoglobinuria: Diagnosis and therapeutic novelties
2021 B. Fattizzo, F. Serpenti, J.A. Giannotta, W. Barcellini
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
2021 M. Capecchi, F. Serpenti, J. Giannotta, L. Pettine, G. Reda, I. Martinelli, A. Artoni, W. Barcellini, B. Fattizzo
Difficult cases of autoimmune hemolytic anemia: A challenge for the internal medicine specialist
2020 B. Fattizzo, J.A. Giannotta, F. Serpenti, W. Barcellini